HK Stock Market Move | INNOGEN-B(02591) rose over 6% again today after surging over 30% yesterday. The company has been included in the Hang Seng Index.

INNOGEN-B(02591) surged over 6% again, with its stock price skyrocketing over 30% yesterday. As of the time of writing, it has risen by 6.11% to 40.3 Hong Kong dollars, with a trading volume of 23.13 million Hong Kong dollars. On the news front, on November 21, the results of the quarterly review of the Hang Seng Index series were announced, with all changes set to take effect from December 8, 2025. Among them, Yinnuo Medicine was included in the Hang Seng Composite Index constituents. A previous research report by Shanghai Securities pointed out that Yinnuo Medicine, with its Supagluca peptide , has good safety and effectiveness in lowering blood sugar and weight, showing significant advantages in the treatment of chronic metabolic diseases such as diabetes, obesity, and fatty liver. The company's listing on the Hong Kong Stock Exchange is expected to further advance its R&D pipeline and commercial expansion.